Following diagnostic criteria, participants with MetS exhibited higher values in blood pressure, waist circumference, BMI, insulin, glucose, triglycerides (TG), HOMA-IR, high-sensitivity C-reactive protein, and lower HDL cholesterol than the control group. This evidence concerns the gene INS and metabolic syndrome.